Table 2.

Frequency of lymphoma and mean survival time (in brackets) of C57BL/6 mice injected intravenously with 164T2 and 164T2S11 lymphoma cells

Lymphoma Cell Line Male Female
164T2  3/8 (58 days) 1/11 (62 days)  
164T2S11  8/8 (16 days) 15/16 (16.5 days) 
Lymphoma Cell Line Male Female
164T2  3/8 (58 days) 1/11 (62 days)  
164T2S11  8/8 (16 days) 15/16 (16.5 days) 

The experiment was terminated at day 90. The data are representative of at least 3 independent experiments.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal